Actionable news
All posts from Actionable news
Actionable news in TRVN: TREVENA Inc,

Trevena to Host Analyst and Investor Day on October 28, 2015

KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Trevena, Inc. (NASDAQ: TRVN), a clinical stage pharmaceutical company focused on the discovery and development of biased ligands targeting G protein coupled receptors (GPCRs), today announced that it will host an Analyst and Investor Day on Wednesday, October 28, 2015 in New York City. Presentations will begin at 12:00 p.m. Eastern Daylight Time and will be streamed simultaneously as a webcast. The event is expected to conclude by 3:00 p.m.

The presentations will focus on the Company’s clinical programs and will feature members of the Trevena management team and leading experts in acute heart failure and pain management, including:

  • G. Michael Felker, M.D., M.H.S., Professor...